Financials
- Market Capitalization 45.01 M
- Employee 20
- Founded 1971
- CEO N/A
- Website www.verupharma.com
- Headquarter Wisconsin, United States
- FIGI BBG000G12J78
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-2.45
売上高対価格比率
12.31
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4297 | CNTX Context Therapeutics Inc. - Common Stock | 0.50 USD | -3.85% | -5.66% | -18.03% | -43.82% | 45.94 M USD | ||
| 4300 | MCRB Seres Therapeutics, Inc. - Common Stock | 4.56 USD | -0.22% | +0.22% | -8.43% | -44.59% | 45.33 M USD | ||
| 4310 | KPTI Karyopharm Therapeutics Inc. - Common Stock | 1.96 USD | +7.69% | -2.97% | -73.69% | -79.67% | 44.46 M USD | ||
| 4315 | TVGN Tevogen Bio Holdings Inc. - Common Stock | 6.75 USD | +5.97% | +2.43% | +48.03% | +625.81% | 43.95 M USD |